Empatica launches EmbraceMini: world's smallest actigraphy wearable for clinical trials.

In an era where artificial intelligence is reshaping industries and daily life, a new frontier is emerging: Emotion AI, also known as affective computing. This technology aims to bridge the gap between human emotions and machine intelligence, changing how we interact with computers and digital systems. Emotion AI encompasses a range of technologies designed to detect, interpret, and respond to human emotional states. These systems use computer vision, voice analysis, biometric sensors and advanced algorithms to discern users’ feelings and moods, opening up new possibilities for personalized and empathetic digital experiences. The foundations of this field trace back to the late 1990s, with pioneering work by researchers like Rosalind Picard at the MIT Media Lab. However, recent advancements in machine learning and sensor technologies have accelerated progress, attracting interest from tech giants and startups alike

The FDA-cleared Empatica Health Monitoring Platform will host all 71 McRoberts endpoints, which will be monitored using Empatica's EmbracePlus wearable. With a modular design, it can be worn on the wrist, waist, hip and other locations on the body, providing a range of versatile digital health measures. (Graphic: Business Wire)The FDA-cleared Empatica Health Monitoring Platform will host all 71 McRoberts endpoints, which will be monitored using Empatica's EmbracePlus wearable. With a modular design, it can be worn on the wrist, waist, hip and other locations on the body, providing a range of versatile digital health measures. (Graphic: Business Wire)BOSTON--(BUSINESS WIRE)--Empatica, a pioneer in digital biomarker development and patient monitoring driven by AI, and McRoberts, one of the leaders in ambulatory monitoring of physical activity, announce the integration of all 71 McRoberts endpoints in Empatica’s digital biomarkers portfolio and FDA-cleared platform, bringing its total offering to over 200.The additional digital biomarkers will enhance the Empatica Health Monitoring Platform with new measures in categories including activity monitoring, energy expenditure, and sleep movements, and introduce key Functional Mobility Assessments such as the sit-to-stand test, gait test, timed up & go test, sway test, and stair test, which play a crucial role in assessing physical function and mobility in clinical care and research settings.“ This partnership shows a maturing digital health industry,” said Matteo Lai, Empatica’s CEO and Co-Founder. “ Established players are joining forces to provide a one-stop solution to sponsors across the world